Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The present and future of synthetic orexin receptor agonists
Tsuyoshi Saitoh, Takeshi Sakurai
Peptides (2023) Vol. 167, pp. 171051-171051
Open Access | Times Cited: 13

Showing 13 citing articles:

Discovery and first-time disclosure of CVN766, an exquisitely selective orexin 1 receptor antagonist
Angela Glen, Roland W. Bürli, David G. Livermore, et al.
Bioorganic & Medicinal Chemistry Letters (2024) Vol. 100, pp. 129629-129629
Open Access | Times Cited: 8
From past to future: 50 years of pharmacological interventions to treat narcolepsy
Éric Konofal
Pharmacology Biochemistry and Behavior (2024) Vol. 241, pp. 173804-173804
Open Access | Times Cited: 6
Narcolepsy and rapid eye movement sleep
Francesco Biscarini, Lucie Barateau, Fabio Pizza, et al.
Journal of Sleep Research (2024)
Open Access | Times Cited: 4
Orexin/hypocretin receptor 2 signaling in MCH neurons regulates REM sleep and insulin sensitivity
Shuntaro Izawa, Debora Fuscà, Hong Jiang, et al.
Cell Reports (2025) Vol. 44, Iss. 2, pp. 115277-115277
Open Access
Rethinking the Role of Orexin in the Regulation of REM Sleep and Appetite
Maria P. Mogavero, Justyna Godos, Giuseppe Grosso, et al.
Nutrients (2023) Vol. 15, Iss. 17, pp. 3679-3679
Open Access | Times Cited: 11
Novel orexin receptor agonists based on arene- or pyridine-fused 1,3-dihydro-2H-imidazole-2-imines
Wentian Wang, Alok Ranjan, Wei Zhang, et al.
Bioorganic & Medicinal Chemistry Letters (2024) Vol. 99, pp. 129624-129624
Open Access | Times Cited: 3
Orexin-mediated Motivated Arousal and Reward Seeking.
Theresa E. Bjorness, Robert Greene
Peptides (2024) Vol. 180, pp. 171280-171280
Closed Access | Times Cited: 3
Hits and misses with animal models of narcolepsy and the implications for drug discovery
Ramakrishna Nirogi, Pradeep Jayarajan, Vijay Benade, et al.
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 6, pp. 755-768
Closed Access | Times Cited: 1
Healthy Sleep, Orexin System and Addiction
Ana Clementina Equihua-Benítez, Fabio Garcı́a-Garcı́a
Revista Internacional de Investigación en Adicciones (2024) Vol. 10, Iss. 1, pp. 80-90
Closed Access | Times Cited: 1
Orexin and Sleep Disturbances in Alpha-Synucleinopathies: a Systematic Review
Kausar Raheel, Qi Rui See, Veronica Munday, et al.
Current Neurology and Neuroscience Reports (2024) Vol. 24, Iss. 9, pp. 389-412
Open Access
Orexin mechanisms in the prelimbic cortex modulate the expression of contextual conditioned fear
Gabriela V. M. Oliveira, Paloma Molina Hernandes, Fábio H. dos Santos, et al.
Psychopharmacology (2024)
Closed Access
Novel applications of sleep pharmacology as delirium therapeutics
Mark Oldham, Adam P. Spira, Michael Yurcheshen, et al.
Sleep Medicine Reviews (2024) Vol. 79, pp. 102016-102016
Closed Access
Narcolepsy Type 1: Should We Only Target Hypocretin Receptor 2?
Rolf Fronczek, Gert Jan Lammers
Clinical and Translational Neuroscience (2023) Vol. 7, Iss. 3, pp. 28-28
Open Access | Times Cited: 1
Page 1

Scroll to top